What type of study is this?

This is a Validation Study study.

What question did this study set out to answer?

This research aims to develop a unified framework for interpreting spatial transcriptomics data in cholangiocarcinoma.

March 22, 2026Open Access

View Full Paper

Ask AI

Bookmark

Authors

Benchmarking dimensionality reduction and spatial autocorrelation in cholangiocarcinoma, suggesting improved targeted therapies.

This research aims to develop a unified framework for interpreting spatial transcriptomics data in cholangiocarcinoma.
Evaluated dimensionality reduction frameworks using a 10x Genomics dataset from 40 cholangiocarcinoma tumor cores.
Introduced Cluster Marker Coherence and Marker Exclusion Rate as new biological metrics.
Developed Hybrid Spatial NMF to enhance spatial representation prior to clustering.
hSNMF outperformed existing dimensionality reduction methods regarding spatial compactness and autocorrelation.
Achieved superior cluster separability and spatial integrity compared to PCA and standard NMF.
Validated computational approach aids in identifying targeted therapies for cholangiocarcinoma.

Mahmud et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark